e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

9.320 -0.200 (-2.10%)

Streaming Delayed Price Updated: 2:53 PM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocular Therapeutix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4 ↗

March 28, 2023

Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...

Via Benzinga

Looking Into Ocular Therapeutix's Return On Capital Employed ↗

March 09, 2023

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

The Latest Analyst Ratings for Ocular Therapeutix ↗

March 07, 2023

Via Benzinga

Earnings Outlook For Ocular Therapeutix ↗

March 03, 2023

Via Benzinga

Why Shares of Ocular Therapeutix Jumped This Week ↗

February 16, 2023

A promising report of a therapy in a phase 1 trial gave the stock a lift.

Via The Motley Fool

Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular Therapeutix: Why These 5 Stocks Are Drawing Heavy Attention Today ↗

February 13, 2023

Major Wall Street indices closed over 1% higher on Monday ahead of the release of the consumer price index report on Tuesday. The Nasdaq Composite closed 1.48% higher while the S&P 500 ended the...

Via Benzinga

Dow Gains Over 300 Points; S&P 500 Up 1% ↗

February 13, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 13, 2023

Via Benzinga

Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet ↗

February 13, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500...

Via Benzinga

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 13, 2023

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.

Via Benzinga

Teradata, Monday.Com And Other Big Stocks Moving Higher On Monday ↗

February 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

US Stocks Open Higher; Dow Jumps 200 Points ↗

February 13, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.59% to 34,069.23 while the NASDAQ rose 0.65% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 13, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!

Via InvestorPlace

Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD ↗

February 13, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 12, 2022

Monday saw 196 companies set new 52-week lows.

Via Benzinga

AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials ↗

November 14, 2022

Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.

Via Benzinga

Ocular Therapeutix And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

November 10, 2022

The Dow Jones dipped by more than 600 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗

November 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗

November 08, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...

Via Benzinga

Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences

November 08, 2022

From Ocular Therapeutix, Inc.

Via Business Wire

Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update

November 07, 2022

From Ocular Therapeutix, Inc.

Via Business Wire

A Preview Of Ocular Therapeutix's Earnings ↗

November 04, 2022

Ocular Therapeutix (NASDAQ:OCUL) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Ocular...

Via Benzinga

Ocular Therapeutix™ To Report Third Quarter 2022 Financial Results

October 24, 2022

From Ocular Therapeutix, Inc.

Via Business Wire

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗

October 05, 2022

Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.

Via InvestorPlace

Nike, Lululemon, Dick's Sporting Goods And Other Big Losers From Friday ↗

October 03, 2022

U.S. stocks closed lower with the Dow Jones dropping 500 points on Friday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy